Standard Operating Procedure: Managing and Executing Mutual Non-Disclosure Agreements (MNDA)

This Standard Operating Procedure (SOP) outlines the professional workflow for identifying, reviewing, and executing a Mutual Non-Disclosure Agreement (MNDA) using a standard template. The objective is to ensure that both parties are protected, intellectual property (IP) is secured, and the agreement is legally binding before the commencement of sensitive business discussions. Failure to execute a proper MNDA can expose organizational trade secrets and sensitive financial data to unauthorized disclosure.

Phase 1: Preparation and Template Selection

• Audit Internal Requirements: Identify the scope of the potential partnership to determine if a "Mutual" agreement (protecting both parties) is necessary, or if a "One-Way" (Unilateral) NDA suffices.
• Source Approved Template: Utilize the firm’s pre-approved legal template. Avoid downloading "free" templates from unverified third-party websites, as these often lack jurisdiction-specific clauses.
• Define Sensitive Information: Clearly define what constitutes "Confidential Information" in the document, including technical data, client lists, pricing strategies, and proprietary code.
• Establish Terminology: Define the "Term" (duration of the agreement) and the "Survival Period" (how long after the partnership ends the confidentiality obligation remains).

Phase 2: Review and Customization

• Verification of Parties: Ensure the legal entity names (including suffixes like Inc., LLC, or Ltd.) are accurate and match official corporate registration records.
• Jurisdiction Clause: Confirm the governing law and venue are set to your home state or country to ensure legal disputes can be managed locally.
• Exclusion Review: Verify the "Exclusions" section, ensuring it covers information already in the public domain or information developed independently by the receiving party.
• Internal Legal Review: Submit the customized draft to your internal legal counsel or compliance officer for a final signature of approval before sending it to the counterparty.

Phase 3: Execution and Filing

• Distribution: Send the MNDA to the counterparty via an e-signature platform (e.g., DocuSign, HelloSign) to ensure a clear audit trail.
• Counterparty Review: Allow the counterparty time to review; be prepared to negotiate clauses such as "Non-Solicitation" or "Residuals."
• Final Signature: Ensure the document is signed by an authorized signatory (e.g., C-level executive or authorized department head).
• Centralized Archiving: Once fully executed, save the document in the company’s secure document management system or encrypted cloud repository, labeled with the date of execution and expiration.

Pro Tips & Pitfalls

• Pro Tip: Always include a "Return or Destroy" clause, which mandates that the counterparty must delete or return all confidential data once the partnership concludes.
• Pro Tip: Use an e-signature service that creates a "Certificate of Completion" to ensure the document is admissible in court.
• Pitfall (Boilerplate Bias): Never treat an NDA as a "simple form." A poorly drafted NDA can create "implied obligations" that restrict your business from entering future markets.
• Pitfall (Over-broad Definitions): Avoid defining "Confidential Information" too broadly; courts may invalidate an NDA if it covers information that is clearly public knowledge.

Frequently Asked Questions (FAQ)

1. Is a "free" template legally enforceable? Templates are legally enforceable only if they are properly drafted for your specific jurisdiction and accurately describe the scope of the relationship. Using a generic template without legal review is risky; always have your legal counsel review the final draft.

2. How long should an MNDA last? While the "Term" of the agreement might be 1–2 years, the "Confidentiality Obligation" (Survival Period) should ideally last 3–5 years, or indefinitely for trade secrets.

3. Can I sign an MNDA on behalf of my team? Generally, only individuals with signatory authority (such as an owner, CEO, or designated VP) should sign NDAs. If you are not in an executive role, seek internal approval from your legal or executive team before signing.